Lee Rauch

President, CEO & Director at Viridian Therapeutics

Lee Rauch is miRagen’s Chief Executive Officer and Board Member.

Ms. Rauch has more than 25 years of experience in the biotech and pharmaceutical industries. She has helped build successful companies that range in size from biotech start-up to multinational pharmaceutical corporation. During this time, she held various executive positions at Global Blood Therapeutics (GBT), Onyx Pharmaceuticals, Nuon Therapeutics, POINT Biomedical, COR Therapeutics, and Syntex Corporation (acquired by Hoffmann-la Roche). She has also served as a consultant to the biotech and pharmaceutical industry. Prior to joining miRagen, she was the Executive in Residence at Columbia Technology Ventures. Until 2015, she held the role of Chief Business Officer at GBT. Prior to GBT, she was President and CEO of Nuon Therapeutics. Before Nuon, she was the Interim Chief Business Officer and V.P. of Corporate Development at Onyx. Earlier in her career she was a founding member of McKinsey & Co.’s Pharmaceutical Practice. Ms. Rauch received her M.B.A. in finance from the University of Chicago and a B.S. in Chemistry from Arizona State University.

Currently, Lee also serves as Executive Chairman to Springboard Enterprises Health Innovation Hub, a private, international organization aimed at accelerating the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts.

Timeline

  • President, CEO & Director

    Current role

View in org chart